IntelliQuit was the 1st place winner of the American Heart Association NYC Hi2 Forum Open Innovation Challenge. This presentation is by Matthew Bars, MS, CTTS, CEO, IntelliQuit, "World's 1st Smartphone Breathalyzer for Smokers."

1. Matthew Bars, MS, CTTS
CEO
Health Sciences Innovation · Investment
Forum
Open Innovation Challenge Finals
April 22nd, 2015
IntelliQuit
World’s 1st Smartphone Breathalyzer for Smokers

2. Smoking is the most important preventable cause of premature death.
Thirty (30%) percent of all coronary heart disease (CHD) is caused by smoking.
Smoking CHD patients experience 50% increase in re-infarction, sudden cardiac
death and total mortality.
These risks drop quickly after tobacco abstinence.
AHA 2020 Impact
Potential

3. SOLUTION
46 million
American adult smokers
23 mm smokers attempt quitting each year
65,000 adults attempt quitting every day
While >70% of all smokers want to quit, research and clinical experience shows fifty percent
(50%) of smokers prefer a progressive managed reduction rather than abrupt abstinence.
IntelliQuit allows the smoker to quit the way they started: One breath, one puff at a time.

4. Wow of the Week
Helping the World’s 1.3 Billion Smokers Quit
PROGRESS

5. INNOVATION & SCALABILITY
How does IntelliQuit work?
Smoker
Expired
Breath
CO

6. INNOVATION & SCALABILITY
Rich functionality and significant insurance revenues

7. MARKET OPPORTUNITY
How will IntelliQuit generate revenue?
Insurance policies re: telemedicine already reimburse for the IntelliQuit ecosystem
Average ecosystem reimbursement $406.21 to $562.40 / 3 mos.
Securing US Durable Medical Device status for 3rd party reimbursement
IntelliQuit device costs ~$33.00 to produce
The stand alone device will retail for $99.99
With 3 months paid treatment support @$16.99/month = $150.96
Additional revenues will be generated from:
Consumer purchase of additional (> 3 mos.) treatment support and ancillary products
(game upgrades, flavored plastic mouthpieces, etc.)
Monetization of our video game, mobile ad sales, rewards, etc…
B2B Verticals include: medical venues, government, business, insurance carriers

8. A Massachusetts state-wide smoking cessation
program reached 37% of all Medicaid smokers
resulting in a 10% reduction in smoking rates.
Statistically significant reductions of 46% in hospital
inpatient admissions for AMI (p<.05), 49% for CAD
(p<.05), and 32% for non-specific chest pain
(p<0.1).
Further, short-term saving >$3.00: $1 spent
Medicaid smokers (~40% vs ~20%)

9. THANKS
Yearning to breathe free